Compare ARK Next Generation Internet ETF (ARKW) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Next Generation Internet ETF vs TransMedics Group Inc — how do they compare? ARK Next Generation Internet ETF trades at $150.99, while TransMedics Group Inc trades at $87.16 (market cap $3.10B). The key difference: ARK Next Generation Internet ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| ARKW | TMDX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $182.20 | $150.42 |
52-Week Low | $114.45 | $61.99 |
Market Cap | — | $3.10B |
Enterprise Value | — | $3.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKW trades at $151.00, up 0.95% with bullish technical signals from moving averages. The ETF faces near-term headwinds from elevated AI infrastructure spending but maintains long-term growth potential through holdings like AMD and TSLA. Technical indicators show mixed signals with RSI suggesting potential overbought conditions while ADX indicates strong trend strength.
The ETF's outlook balances near-term capital expenditure pressures against long-term AI growth opportunities. Key risks include market skepticism toward tech valuations and sector volatility, while institutional interest in AI exposure provides support. Current positioning near resistance at $152 suggests potential for consolidation before next directional move.
TransMedics Group (TMDX) trades at $87.42, down 1.12% on the day, with a bullish technical outlook from moving averages but bearish oscillators signaling potential overbought conditions. The company reported mixed Q2 2026 results, missing earnings estimates with EPS of $0.44 versus $0.50 expected, while revenue growth remains robust. Recent news highlights an ongoing investigation into fiduciary duties by directors, adding uncertainty.
The stock presents a cautious opportunity with strong analyst support (69% buy ratings) and a consensus price target of $99.57, implying upside, but risks include earnings volatility, margin pressures, and legal scrutiny. Fundamentals show solid profitability with a 22.69% net margin, though valuation multiples like P/E of 23.15 suggest premium pricing relative to historical norms.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Next Generation Internet ETF
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
